๐ฌ The latest report from the Public Policy Projects' team calls for significant reforms in approaches to genomic testing in cancer care, highlighting key challenges and solutions. By addressing process and capacity issues, enhancing pathology lab resources, creating a centralised clinical trials database and increasing clinician education and awareness, the report aims to improve patient outcomes and ensure equitable access to genomic testing across the UK. ๐ Despite advancements, disparities in access remain, underscoring the need for a cultural shift in genomic medicine. You can find the full report below ๐
๐ New Report* Launch: Transforming Genomic Testing in Cancer Care We are excited to announce the launch of our latest report, โ๐๐ฆ๐ฉ๐ซ๐จ๐ฏ๐ข๐ง๐ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐๐๐ง๐จ๐ฆ๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ง๐ ๐๐๐๐ข๐๐ข๐ง๐ ๐๐จ๐ซ ๐๐๐ง๐๐๐ซ: ๐๐จ๐จ๐ฌ๐ญ๐ข๐ง๐ ๐๐ฎ๐ญ๐๐จ๐ฆ๐๐ฌ ๐๐ง๐ ๐๐๐๐ฎ๐๐ข๐ง๐ ๐๐ง๐๐ช๐ฎ๐๐ฅ๐ข๐ญ๐ข๐๐ฌ." This comprehensive study by PPP calls for a significant overhaul in the NHS's approach to genomic testing in cancer care. ๐ฌ Key Findings: - Process & Capacity Issues: Onerous processes and lack of understanding by clinicians are major barriers. - Pathology Lab Resources: Increased capacity and better technology implementation are crucial. - Centralised Clinical Trials Database: A unified system for clinical trials is needed to enhance access and scientific discovery. - Education & Awareness: Clinicians need better education and support to advocate for genomic testing. ๐ Despite advancements, there are still variations in access to genomic testing across the UK. Many clinicians are not fully aware of the benefits, highlighting the need for a robust education programme. ๐ฌ Dr. Tony Patrikios, Executive Medical Director at Amgen UK, comments: โRapid and easy access to genomic testing in cancer is crucial for delivering personalised, effective, and efficient healthcare, improving outcomes, and advancing our understanding and treatment of cancer. Equally important is ensuring that access to such testing is equitable for all patients." Join us in supporting the call for a culture shift in genomic medicine within the NHS. Together, we can make genomic testing as routine and straightforward as a blood test, ensuring every patient benefits from the latest advancements in cancer care. Read the full report here: https://lnkd.in/dUzQqePM *Amgen have provided sponsorship to support the delivery of the PPP Cancer Care Programme. PPP retains editorial control across all policy programmes. #GenomicTesting #CancerCare #HealthcareInnovation #CancerResearch Rachel Millar
Working with senior leaders and valued partners across healthcare and life sciences
1wThank you Lifebit. This is hugely important work and will be a central theme in our autumn schedule of conferences across #oncology #genomics #raredisease and #precisionmedicine. I look forward to discussing how Public Policy Projects and Lifebit can partner to build on the recommendations in this report.